Extracellular chaperonin 10 augments apoptotic cell death induced by 5-fluorouracil in human colon cancer cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Kun | - |
dc.contributor.author | Yeo, Seung-Gu | - |
dc.date.accessioned | 2021-08-11T22:24:30Z | - |
dc.date.available | 2021-08-11T22:24:30Z | - |
dc.date.issued | 2014-11 | - |
dc.identifier.issn | 0300-8916 | - |
dc.identifier.issn | 2038-2529 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/11753 | - |
dc.description.abstract | Aims and background. The molecular mechanisms involved in resistance to 5-fluorouracil (5-FU) in colon cancer patients remain to be elucidated. The purpose of this study was to identify proteins associated with 5-FU resistance in colon cancer. Methods and study design. Proteins secreted from a 5-FU-resistant human colon cancer cell line (SNU-C4 5-FU 200) were analyzed by two-dimensional gel electrophoresis- based proteomics, and identified using matrix-associated laser desorption/ionization-mass spectroscopy analysis and SWISS-PROT database searches. The expression levels of candidate proteins were determined by Western blotting and cell proliferation was monitored by MTT assay. Results. Chaperonin 10 (cpn10) was secreted at a lower level by 5-FU-resistant cells compared to the non-resistant parent cell line. The proliferation of both the parent and 5-FU-resistant cell lines increased slightly when extracellular cpn10 alone was added. However, in the presence of 5-FU, cpn10 augmented 5-FU-induced apoptotic death in both cell lines. Cpn10 led to activation of extracellular signal-regulated kinase 1/2 (ERK 1/2), and a specific ERK 1/2 inhibitor, PD98059, completely inhibited cpn10-stimulated cell proliferation. Conclusions. Our findings indicate that concurrent treatment with cpn10 and 5-FU warrants further investigation in an effort to overcome 5-FU resistance and enhance the efficacy of 5-FU therapy for colon cancer. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | II Pensiero Scientifico Editore srl | - |
dc.title | Extracellular chaperonin 10 augments apoptotic cell death induced by 5-fluorouracil in human colon cancer cells | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1177/1778.19282 | - |
dc.identifier.scopusid | 2-s2.0-84923300834 | - |
dc.identifier.wosid | 000349602800002 | - |
dc.identifier.bibliographicCitation | Tumori, v.100, no.6, pp E230 - E235 | - |
dc.citation.title | Tumori | - |
dc.citation.volume | 100 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | E230 | - |
dc.citation.endPage | E235 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | EARLY-PREGNANCY FACTOR | - |
dc.subject.keywordPlus | PROTEIN-KINASE | - |
dc.subject.keywordPlus | COLORECTAL-CANCER | - |
dc.subject.keywordPlus | LARGE-BOWEL | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | HSP10 | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordPlus | SYNTHASE | - |
dc.subject.keywordPlus | HSP60 | - |
dc.subject.keywordAuthor | 5-fluorouracil | - |
dc.subject.keywordAuthor | colon cancer | - |
dc.subject.keywordAuthor | chaperonin | - |
dc.subject.keywordAuthor | drug resistance | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.